|

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

RECRUITINGN/ASponsored by Ohio State University Comprehensive Cancer Center
Actively Recruiting
PhaseN/A
SponsorOhio State University Comprehensive Cancer Center
Started2019-03-26
Est. completion2026-09-15
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03711890

Summary

This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Immediate surgery cohort: Adult patients with pancreatic cancer or IPMN
* Immediate surgery cohort: Informed consent will be obtained
* Adult patients undergoing pancreatic resection for a presumed IPMN

Exclusion Criteria:

* Pregnant

Conditions3

CancerPancreatic CarcinomaPancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type

Locations1 site

Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210
Mary E. Dillhoff, MD614-293-7171Mary.Dillhoff@osumc.edu

Find trials near these locations

Cancer trials in ColumbusAll trials in Ohio

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.